SPBC660.05 Antibody

What is SPBC660.05 and why is it studied using antibody-based techniques?

SPBC660.05 is a protein in Schizosaccharomyces pombe (fission yeast) that belongs to the same family as SPBC660.07 (ntp1), which functions as an O-glycosyl hydrolase . Antibodies against SPBC660.05 are valuable tools for characterizing protein expression, localization, and function in cellular pathways.

Researchers typically employ these antibodies in multiple experimental contexts:

• Western blotting for protein expression analysis

• Immunofluorescence microscopy for subcellular localization

• Immunoprecipitation for protein-protein interaction studies

• Chromatin immunoprecipitation if the protein has nuclear functions

The protein's importance stems from its potential role in cellular metabolism and signal transduction pathways, making it relevant for understanding fundamental cellular processes in this model organism.

What types of antibodies against SPBC660.05 are commonly used in yeast research?

Several types of antibodies are employed when studying SPBC660.05:

When selecting antibodies for SPBC660.05 studies, researchers often use monoclonal antibodies like TAT-1 (for tubulin) as loading controls or reference markers . The choice depends on whether native protein detection is required or if tagged constructs can be employed.

How should I optimize Western blotting protocols for SPBC660.05 detection?

Optimizing Western blotting for SPBC660.05 detection requires attention to several parameters:

• Sample preparation:

  • Use lysis buffers containing protease inhibitors to prevent degradation

  • For membrane-associated proteins, consider specialized detergent-based extraction

  • Typical loading: 15-25 μg of total protein per lane

• Gel percentage optimization:

  • Based on similar SPBC family proteins, use 10-12% SDS-PAGE gels

  • Consider gradient gels (4-15%) for better resolution

• Transfer conditions:

  • For proteins >50 kDa: overnight transfer at 30V (4°C)

  • For proteins <50 kDa: 1-2 hour transfer at 100V

• Blocking and antibody incubation:

  • Test both BSA and milk-based blocking solutions (5%)

  • Primary antibody dilutions: start with 1:1000 and optimize

  • Secondary antibody dilutions: typically 1:5000-1:10000

  • Consider overnight primary antibody incubation at 4°C for improved signal

• Detection optimization:

  • Use appropriate anti-mouse or anti-rabbit secondary antibodies conjugated to HRP

  • For low abundance proteins, consider enhanced chemiluminescence systems

What controls should I include when using SPBC660.05 antibodies?

Proper experimental controls are essential when working with SPBC660.05 antibodies:

• Positive controls:

  • Lysate from wild-type S. pombe expressing SPBC660.05

  • Lysate from cells overexpressing SPBC660.05

  • Purified recombinant SPBC660.05 protein (if available)

• Negative controls:

  • Lysate from SPBC660.05 deletion mutant (ΔSPBC660.05)

  • Pre-immune serum (for polyclonal antibodies)

  • Isotype control (for monoclonal antibodies)

• Specificity controls:

  • Peptide competition assay: pre-incubating antibody with immunizing peptide

  • siRNA/knockout validation: signal should decrease in cells with reduced expression

• Loading and transfer controls:

  • Anti-tubulin antibodies (e.g., TAT-1) as a housekeeping protein control

  • Total protein staining (e.g., Ponceau S)

Each control serves to validate the specificity and reliability of the antibody signal, helping distinguish between genuine protein detection and experimental artifacts.

How can I use SPBC660.05 antibodies for co-immunoprecipitation to identify protein interaction partners?

Co-immunoprecipitation (Co-IP) with SPBC660.05 antibodies can identify interaction partners through this optimized protocol:

• Sample preparation:

  • Use gentle lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40) with protease inhibitors

  • Avoid harsh detergents that may disrupt protein-protein interactions

  • Typical starting material: 2-5 mg of total protein from S. pombe cultures

• Pre-clearing step:

  • Incubate lysate with protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation to reduce non-specific binding

• Immunoprecipitation:

  • Incubate pre-cleared lysate with 2-5 μg of SPBC660.05 antibody overnight at 4°C

  • Add 30-50 μl of protein A/G beads and incubate for 2-4 hours

  • Wash beads 4-5 times with wash buffer (lysis buffer with reduced detergent)

• Elution and analysis:

  • Elute bound proteins with SDS sample buffer at 95°C for 5 minutes

  • Analyze by SDS-PAGE followed by silver staining or mass spectrometry

  • For Western blot detection, use methods similar to those employed for TAT-1 antibody

• Controls:

  • IgG control: perform parallel IP with non-specific IgG

  • Input control: analyze 5-10% of pre-IP lysate

  • Reciprocal IP: confirm interactions by IP with antibodies against identified partners

For validation of novel interaction partners, combine co-IP with orthogonal methods such as yeast two-hybrid or in vitro binding assays to confirm direct interactions.

What approaches are most effective for using SPBC660.05 antibodies in chromatin immunoprecipitation (ChIP) experiments?

If SPBC660.05 has chromatin-associated functions, optimizing ChIP protocols involves:

• Crosslinking optimization:

  • Test various formaldehyde concentrations (0.75-1.5%)

  • Optimize crosslinking time (5-20 minutes at room temperature)

  • Consider dual crosslinking with DSG/formaldehyde for improved efficiency

• Sonication parameters:

  • Aim for DNA fragments of 200-500 bp

  • Optimize cycles, amplitude, and duration based on your sonicator

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation:

  • Use 3-5 μg of SPBC660.05 antibody per ChIP reaction

  • Include IgG control and input samples (5-10%)

  • Consider pre-adsorption of antibody to beads before adding chromatin

• Washing and elution:

  • Use increasingly stringent wash buffers to reduce non-specific binding

  • Elute at 65°C in elution buffer (1% SDS, 100 mM NaHCO3)

  • Reverse crosslinks overnight at 65°C

• Analysis methods:

  • qPCR for known or suspected binding sites

  • ChIP-seq for genome-wide binding profile

When optimizing ChIP for SPBC660.05, start with regions of known or predicted binding based on sequence homology to similar proteins, then expand to genome-wide analyses after validating the protocol with positive controls.

How can I resolve specificity issues with SPBC660.05 antibodies?

Researchers may encounter specificity issues with SPBC660.05 antibodies, which can be addressed through:

• Epitope mapping:

  • Determine which region of SPBC660.05 the antibody recognizes

  • Use peptide arrays or deletion constructs to map the exact epitope

  • This helps predict potential cross-reactivity with similar proteins

• Cross-reactivity assessment:

  • Test antibody against recombinant proteins with similar sequences

  • Evaluate signal in cells with SPBC660.05 knocked out

  • Compare results with multiple antibodies targeting different epitopes

• Improving specificity:

  • Affinity purification against the immunizing antigen

  • Pre-adsorption against proteins causing cross-reactivity

  • Consider using multiple antibodies in parallel for validation

• Alternative validation approaches:

  • Use orthogonal methods (e.g., mass spectrometry) to confirm antibody findings

  • Create epitope-tagged versions of the protein for validation

  • Use gene editing techniques to tag endogenous SPBC660.05

• Quantitative assessment:

  • Calculate signal-to-noise ratios under different conditions

  • Determine the most specific detection methods for your experimental system

Similar approaches have been successful in validating antibodies against other yeast proteins, as demonstrated in studies using the TAT-1 antibody for tubulin detection .

What are the optimal conditions for immunofluorescence microscopy using SPBC660.05 antibodies?

For immunofluorescence microscopy in S. pombe using SPBC660.05 antibodies:

• Fixation methods comparison:

  Method	Advantages	Disadvantages	Recommended For
  4% paraformaldehyde	Preserves structure	Some epitopes masked	General localization
  Methanol (-20°C)	Better for some epitopes	Can distort membranes	Nuclear proteins
  Formaldehyde + glutaraldehyde	Superior membrane preservation	Strong autofluorescence	Membrane proteins

• Permeabilization optimization:

  • For cell wall digestion in yeast, use zymolyase or lysing enzymes

  • Test various detergents (0.1-0.5% Triton X-100, 0.05% SDS)

  • Balance between accessibility and structural preservation

• Blocking conditions:

  • 3-5% BSA or 5-10% normal serum from secondary antibody host

  • Include 0.1% Tween-20 to reduce non-specific binding

  • Block for 30-60 minutes at room temperature

• Antibody incubations:

  • Primary: 1:100-1:500 dilution, overnight at 4°C

  • Secondary: 1:500-1:1000 dilution, 1-2 hours at room temperature

  • Include DAPI (1 μg/ml) for nuclear staining

• Mounting and imaging:

  • Use anti-fade mounting medium to prevent photobleaching

  • Acquire Z-stacks (0.2-0.5 μm steps) for 3D reconstruction

  • Use appropriate filter sets and exposure times

For SPBC660.05 localization studies, co-staining with the TAT-1 antibody (for tubulin) can provide valuable reference for subcellular structures and cell cycle stages.

How can I quantitatively analyze SPBC660.05 expression levels under different experimental conditions?

Quantitative analysis of SPBC660.05 expression requires rigorous methodology:

• Quantitative Western blotting approach:

  • Use internal loading controls (tubulin with TAT-1 antibody)

  • Include a standard curve of recombinant protein if available

  • Use fluorescent secondary antibodies for wider dynamic range

  • Image using systems with linear detection capabilities

• Flow cytometry for single-cell analysis:

  • Fix and permeabilize cells appropriately for intracellular staining

  • Use directly conjugated primary antibodies if available

  • Include isotype controls to set gates

  • Measure median fluorescence intensity (MFI) for quantification

• Quantitative mass spectrometry:

  • Use SILAC, TMT, or label-free quantification

  • Include internal standard peptides

  • Focus on unique peptides from SPBC660.05

  • Analyze multiple peptides per protein for confidence

• Data analysis and normalization:

  • Use appropriate statistical tests (t-test, ANOVA)

  • Apply multiple testing corrections for large-scale experiments

  • Present data with appropriate error bars (SD, SEM)

  • Validate findings with orthogonal methods

Example quantification table for comparing SPBC660.05 expression under various stress conditions:

How can I determine if post-translational modifications of SPBC660.05 affect antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody binding:

• Identifying potential PTM sites:

  • In silico prediction using tools like NetPhos, GPS, SUMOsp

  • Mass spectrometry analysis of purified SPBC660.05

  • Comparison with known modifications in homologous proteins

• Testing PTM effects on antibody binding:

  • Compare recognition of native vs. dephosphorylated protein

  • Use phosphatase treatment before Western blotting

  • Generate phospho-mimetic mutants (S/T to D/E) and phospho-null mutants (S/T to A)

• Developing modification-specific antibodies:

  • Generate antibodies against peptides containing modified residues

  • Validate specificity using peptide competition assays

  • Confirm using mutant proteins lacking modification sites

• Comparative analysis techniques:

  • 2D gel electrophoresis to separate modified forms

  • Phos-tag gels to resolve phosphorylated species

  • Mobility shift assays to detect large modifications

When optimizing antibody protocols, consider how different sample preparation methods might affect the preservation or accessibility of important PTMs that could influence antibody recognition and experimental outcomes.

What strategies can resolve contradictory results from different SPBC660.05 antibody-based experiments?

When experiments using SPBC660.05 antibodies yield contradictory results, systematic troubleshooting includes:

• Epitope mapping and accessibility:

  • Determine which protein regions each antibody recognizes

  • Assess accessibility of epitopes in different experimental conditions

  • Consider protein conformation in native vs. denatured states

• Comparative antibody profiling:

  • Test all antibodies in parallel under identical conditions

  • Compare specificity, sensitivity, and reproducibility

  • Determine which applications each antibody is suited for

• Technical reconciliation approaches:

  • Adjust fixation methods for immunofluorescence

  • Modify extraction conditions for Western blotting

  • Test different blocking agents and incubation conditions

• Biological explanations for discrepancies:

  • Post-translational modifications affecting epitope recognition

  • Protein isoforms with different antibody reactivity

  • Conformational changes masking epitopes under certain conditions

• Resolution strategies:

  • Use complementary techniques not dependent on antibodies

  • Employ tagged SPBC660.05 constructs when possible

  • Consider structural biology approaches to understand protein conformation

Similar approaches have been successful in resolving contradictory results in studies of other fission yeast proteins, as shown in research using the TAT-1 antibody alongside other methods .

How can SPBC660.05 antibodies be used to study protein dynamics during the cell cycle?

To study SPBC660.05 dynamics throughout the cell cycle:

• Synchronization methods for S. pombe:

  • Nitrogen starvation and release

  • Centrifugal elutriation

  • Genetic methods (temperature-sensitive cdc mutants)

  • Chemical synchronization (hydroxyurea block and release)

• Time-course sampling:

  • Collect samples at 15-20 minute intervals following synchronization

  • Monitor synchrony using morphological markers and DNA content

  • Process parallel samples for protein and microscopy analysis

• Protein analysis techniques:

  • Western blotting with SPBC660.05 antibodies at each time point

  • Immunoprecipitation to detect cell-cycle-specific interactions

  • Phosphorylation-specific antibodies if applicable

• Microscopy approaches:

  • Fixed-cell immunofluorescence at each time point

  • Co-staining with cell cycle markers (e.g., tubulin using TAT-1)

  • Quantitative image analysis of protein localization and abundance

• Data integration:

  • Correlate expression level, modification state, and localization

  • Compare to known cell cycle regulators

  • Generate mathematical models of protein dynamics

This approach allows researchers to determine how SPBC660.05 expression, localization, and interactions change during cell cycle progression, potentially revealing functional roles in specific cell cycle phases.

What methods can combine SPBC660.05 antibodies with high-throughput screening approaches?

Integrating SPBC660.05 antibodies into high-throughput screens offers powerful discovery potential:

• Antibody-based genome-wide screens:

  • Systematic gene deletion libraries with SPBC660.05 immunostaining

  • RNAi screens followed by quantitative Western blotting

  • CRISPR screens with antibody-based readouts

• High-content imaging approaches:

  • Automated immunofluorescence in multi-well format

  • Machine learning for phenotype classification

  • Correlative analysis of multiple cellular markers

• Protein-protein interaction screens:

  • IP-mass spectrometry under various conditions

  • Protein complementation assays with SPBC660.05 fragments

  • Membrane-based antibody arrays for interaction profiling

• Small molecule screening:

  • Compound libraries tested for effects on SPBC660.05 expression/localization

  • Antibody-based detection of changes in protein levels or modifications

  • Target identification using affinity-based approaches

• Data analysis frameworks:

  • Multivariate statistical methods for complex phenotypes

  • Network analysis to place SPBC660.05 in cellular pathways

  • Integration with existing genomic and proteomic datasets

These approaches have been employed in similar studies of S. pombe proteins, enabling researchers to place individual proteins within broader functional networks and identify novel regulatory mechanisms.

How should I troubleshoot non-specific binding when using SPBC660.05 antibodies in complex yeast extracts?

Non-specific binding can complicate experiments with SPBC660.05 antibodies:

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, milk, normal serum)

  • Increase blocking concentration (3-5%)

  • Add detergents (0.1% Tween-20 or 0.1% Triton X-100)

  • Extend blocking time (1-2 hours at room temperature)

• Antibody dilution and incubation:

  • Test serial dilutions to identify optimal concentration

  • Reduce incubation temperature (4°C instead of room temperature)

  • Add carrier proteins (0.1-0.5% BSA) to antibody diluent

  • Use longer incubation times with more dilute antibody solutions

• Wash optimization:

  • Increase number of washes (5-6 times)

  • Extend wash duration (10-15 minutes each)

  • Add detergent to wash buffers (0.1-0.5% Tween-20)

  • Use higher salt concentration (250-500 mM NaCl) in wash buffers

• Pre-absorption techniques:

  • Pre-incubate antibody with proteins causing cross-reactivity

  • Use extracts from SPBC660.05 deletion strains for pre-absorption

  • Consider affinity purification of antibodies

• Detection system modifications:

  • Reduce exposure time in chemiluminescence detection

  • Use more stringent settings for fluorescent detection

  • Consider alternative secondary antibodies or detection systems

Comparing results with those obtained using well-characterized antibodies like TAT-1 can help establish appropriate conditions and controls for minimizing non-specific binding in your experimental system.